EHR vendors ask FDA for revisions to clinical decision support software guidance

EHR vendors ask FDA for revisions to clinical decision support software guidance

In a letter, the HIMSS EHR Association expresses concerns and asks for answers on matters like automation bias and how the sector would move away from antiquated systems. This week, the U.S. Food and Drug Administration received a letter from the HIMSS Electronic Health Record Group, a national trade association of EHR developers with 30 member businesses, highlighting issues with the regulatory body's clinical decision support software final Guidance. Section 520 of the Federal Food, Drug & Cosmetic Act was modified by the 21st Century Cures Act to exclude some medical software functionalities, such as specific decision support software, from the definition of device. While noting that its members have contributed, the EHR Association stated in a letter dated December 6.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 1, 2024 at 1:10pm